Modernizing Clinical Trial Recruitment: From Visibility to Control

Recruitment is often described as the most unpredictable part of a clinical trial. In reality, much of the unpredictability emanates from a familiar problem: fragmented data and limited visibility across the actual patient journey.

Just as drug supply reconciliation has historically relied on stitching together EDC, IRT, and depot data, patient recruitment faces a similar challenge. Critical signals, ranging from referrals and prescreening outcomes to site activities and actual enrollment, live in different systems that don’t really speak to each other.

The result is not just inefficiency, but missed opportunities to actively optimize enrollment into clinical trials.

The Reality: Recruitment Data Is Everywhere

To understand recruitment performance, teams must pull from multiple sources:

• Recruitment vendors and ad platforms (e.g., Google, Instagram, Facebook)
• Study websites (e.g., Google Analytics)
• Site-reported referrals
• Prescreener questionnaires and responses
• EDC systems for screening, screen failures, and randomization

Each source answers a different question:

• How many patients are expressing interest?
• How many are qualified?
• How many actually show up at sites?
• How many ultimately randomize?

Without properly consolidating information, these remain disconnected snapshots rather than a comprehensive funnel.

The Consequence: Monitoring Without Control

Most teams can report on recruitment metrics with manual trackers. Far fewer can influence them in real time.

Common challenges include:

• Overloading sites with referrals they cannot handle
• Sending low-quality referrals that lead to high screen failure rates
• Inefficient ad spend targeting geographies without active sites
• Lack of alignment between recruitment efforts and actual site capacity

This leads to a frustrating dynamic where teams react to enrollment trends after the fact, rather than shaping them proactively and quickly.

The Hidden Cost: Eroding Patient Trust

Operational fragmentation doesn’t only impact study timelines, but it impacts the most important thing: patient experience and trust.

Patients are often navigating:

• long consent forms
• confusing medical terminology
• multiple handoffs between systems and coordinators
• inconsistent communication throughout the enrollment process

At the same time, sites are frequently overwhelmed by referral volume that may not align with actual capacity or patient qualification criteria.

The result can be a frustrating experience for both patients and site staff:

• delayed follow-up
• repeated intake questions
• unclear expectations
• higher screen failure rates

As discussed during recent industry conversations at Fierce Biotech Week 2026, recruitment challenges are increasingly being viewed not only as operational problems, but also as trust and experience problems.

Improving recruitment therefore requires more than generating referrals. It requires creating a patient journey that feels coordinated, transparent, and manageable from initial interest through enrollment.

Beyond ClinicalTrials.gov: Building a True Recruitment Engine

While ClinicalTrials.gov is essential for transparency, it is not a recruitment engine.

Modern trials increasingly rely on:

• Dedicated study websites to educate and engage patients
• Digital advertising (e.g., Google, social media) to drive awareness
• Prescreeners to qualify patients before they reach sites

These channels introduce a powerful new lever: control over referral volume and quality.

The Missing Link: Connecting Referrals to Enrollment Outcomes

The real challenge is not generating referrals, but understanding their true downstream impact.

For example:

• Are referrals from a specific campaign actually converting to randomizations?
• Which sites are receiving more referrals than they can process?
• Where are patients dropping off? Are they starting the prescreen questionnaire? Do they stop filling out questions because it’s too long? Do they come in for screening and also come back to enroll?

Answering these questions requires connecting:

• Top-of-funnel data (ads, website traffic)
• Mid-funnel data (prescreener outcomes, referrals)
• Bottom-of-funnel data (EDC: screening, screen failures, randomization, end of treatment, end of study)

Without this linkage, optimization is guesswork.

From Visibility to Control: Actively Managing Recruitment

With an integrated, end-to-end view, recruitment becomes something teams can actively manage throughout the course of study.

1. Controlling Referral Volume by Site

Not all sites are equal in capacity.

If a site can handle 100 referrals in a given week, sending 200 creates operational strain and poor patient experience. Instead, teams can:

• Adjust ad targeting based on site capacity
• Control referral flow geographically (e.g., radius targeting around active sites)
• Pause or throttle campaigns when sites reach capacity

2. Improving Referral Quality

Sites quickly disengage when referrals are consistently unqualified.

By linking prescreener data and screen failure rates back to recruitment sources, teams can:

• Identify high-performing channels
• Eliminate low-quality traffic
• Refine targeting criteria

3. Optimizing Spend with Precision

Recruitment budgets are finite.

Without visibility, teams risk spending in regions without active sites or where enrollment is already saturated. With better data, they can:

• Focus spend around high-performing sites
• Avoid unnecessary geographic coverage
• Continuously reallocate budget based on performance

4. Validating Site-Level Assumptions

Teams often categorize sites based on expected performance.

Some sites are expected to be high enrollers, while others low or even zero. However, without data, these assumptions remain static.

By connecting referral activity to actual enrollment outcomes, teams can:

• Validate whether sites are performing as expected
• Adjust recruitment strategies in real time
• Better align enrollment with study timelines and budgets

A Familiar Pattern: From Manual Tracking to Integrated Insight

Today, many of these workflows are still managed manually: exporting reports, reconciling spreadsheets, and attempting to piece together the patient journey.

This mirrors the same challenges seen in drug supply management.

The shift underway is similar as well:

• From siloed systems to integrated data
• From retrospective reporting to forward-looking insight
• From passive monitoring to active control

Conclusion

Recruitment doesn’t have to be unpredictable.

With the right visibility across the full patient funnel, from initial interest via ads to randomization and eventually study completion, teams gain the ability to not only understand performance, but to shape the overall journey.

By aligning referrals with site capacity, improving patient quality, and maximizing the impact of every dollar spent, there’s tremendous opportunity to recruit faster and smarter.